SCHEMBL13409073

SCHEMBL13409073

CC1(C)c2ccccc2N(c2ccc(-c3cc4cc(-c5ccc6ccccc6c5)c5ccccc5c4c4ccccc34)cc2)c2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HTT P42858 1/20 0.34
GSTP1 P09211 1/20 0.34
GPR84 Q9NQS5 1/20 0.33
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.33
AKT1 P31749 1/20 0.32
PDE6D O43924 1/20 0.32
CYP1A2 P05177 2/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
CYP2B6 P20813 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13408795 0.93 KMT2A (0.34) KMT2AKDM4EMEN1MAPTHTT
SCHEMBL13409052 0.90 PDE6D (0.37) KMT2AKDM4EMEN1MAPTALDH1A1
SCHEMBL13408887 0.89 KDM4E (0.35) KMT2AKDM4EMEN1MAPTALDH1A1
SCHEMBL13409045 0.87 MEN1 (0.37) KMT2AKDM4EMEN1MAPTALDH1A1
SCHEMBL13408728 0.85 PGR (0.35) KMT2AKDM4EMEN1MAPTALDH1A1
SCHEMBL13409054 0.83 GPR84 (0.36) KDM4EMAPTALDH1A1GSTP1GPR84
SCHEMBL13409074 0.81 GPR84 (0.35) GSTP1GPR84AKT1PDE6DCYP1A2
SCHEMBL13706110 0.81 PTGS2 (0.35) KMT2AKDM4EMEN1MAPTALDH1A1
SCHEMBL13409057 0.81 GSTP1 (0.36) ALDH1A1GSTP1GPR84AKT1PDE6D
SCHEMBL13557640 0.81 MAPT (0.34) KMT2AKDM4EMEN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same GRACEL DISPLAY INC. (KR) 2010-04-22 US disclosed
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same GRACEL DISPLAY INC. (KR) 2010-04-22 US disclosed
EP-2161319-A2 Benzo(c)phenanthrene derivatives and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-03-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same OCIAD1, OR10J3, ORMDL3 KMT2A 3511/4885KDM4E 4170/4885MEN1 3162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.